.  Admin and other expenses were Bt4,198mn increasing 2.7% but declining 1.3% QoQ mainly due to staff cost. Net FX gain was Bt84mn increasing from Bt129mn net loss 1Q18 but decreasing from Bt129mn net gain

2017 following a focus on quality acquisition in both mobile and fixed broadband. Net FX gain was Bt119mn decreasing from Bt225mn in 2017. FX gain/ loss was incurred from CAPEX payables due to currency

network expansion led to increasing cost of service 3.9%YoY and 3.4%QoQ; however, SG&A was well-managed and dropped -12%YoY and -8.8%QoQ, resulted in stabilized EBITDA with -0.9%YoY and +1.6%QoQ. Net profit

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

Company and its subsidiaries consists of agent fee income, interest income, gain on exchange rate and gain on short-term investment. For the three-month period ended 31 March 2019, other income totaled THB

0.73 million Baht and 2.12 million Baht, which were sales of scrap materials, interest income, gain on changes in fair value of short-term investment, and gain on exchange rates, etc. The other income

, accounting of 14.7% of total revenue, showing an increase of 389 million baht or 13.5% y-y. Other revenues consist of bad debt recovery, which was 1,696 million baht, 19.2% growth y-y, gain on sales of written

robust operational performance across all our assets. The on-going structural changes in the PET industry created opportunity for well-managed and committed producers to align supply reliability and

FY21, turned negative, compared to FX gain of Bt2mn in FY20 duet to THB depreciation and increased capex payable. Finance cost was Bt5,626mn, decreasing -4.9% YoY from lower interest-bearing debt

purchase of receivables and loans 549.6 20.0% 552.6 20.7% 3.0 0.5% Gain on loans receivable from purchase of accounts receivable 88.3 3.2% 232.8 8.7% 144.5 163.6% Rental income 124.2 4.5% 93.7 3.5% -30.5